Trial
NCT02421575
Hydroxychloroquine in Blocking Autophagy in Patients With Prostate Cancer Undergoing Surgery or Active Surveillance
Early Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Rutgers, The State University of New Jersey
Collaborators
National Cancer Institute (NCI); Rutgers Cancer Institute of New Jersey
Condition
Prostate Carcinoma
Intervention
Hydroxychloroquine
Why stopped
slow accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-02-02